social.eyeforpharma.comReuters Events | Pharma

-- Login Username or e-mail * Password * Forgotten Password? Subscribe | Forgot your password? Close log in window On Demand | -- Newsletter | Log In Thought leadership and innovation for the Pharmaceutical Industry Search this site Home Topics Commercial Access and Evidence Clinical Patients and Medical Research Reports White Papers and reports Conference Slides, Videos, Audio Webinars Events About/contact Contact Us Management Team Sponsor content Menu -- Fixing the broken patient search experience There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in? Medical On the journey from pill to platform As pharma’s business model increasingly moves beyond the pill towards the patient and the entire therapeutic context, Medical... Medical From insight to action in medical affairs The context of most human engagement has been limited to the digital space thanks to the current pandemic. Around two thirds... Latest Patients and Medical Optimizing patient Engagement in Trials Joseph Constance , ( May 23, 2021 ) The importance of involving the patient at all stages of trials post-pandemic has never been clearer Patients and Medical Fixing the broken patient search experience Andrew Stone , ( May 23, 2021 ) There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in? Access and Evidence Including the caregiver in access submissions Katie Osborne , ( May 23, 2021 ) Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence Medical From insight to action in medical affairs Nicola Davies , ( May 6, 2021 ) Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them Clinical How collaboration will strengthen the future of cell and gene therapies Adlai Goldberg , ( Apr 6, 2021 ) As clinical science continues to deliver on the promise of CGT, how can the industry make them available and affordable at scale? More Content Most Popular Fixing the broken patient search experience Andrew Stone , ( May 23, 2021 ) There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in? From insight to action in medical affairs Nicola Davies , ( May 6, 2021 ) Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them Including the caregiver in access submissions Katie Osborne , ( May 23, 2021 ) Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence Opinion Up close and personal: Reacting in a crisis - The Naji Gehchan story Jill Donahue , ( Mar 11, 2021 ) This pharma leader worked in a war zone. Now he’s using the same tactics to navigate the pandemic Up close and personal: A life of service - The Dr. Dirk Vander Mijnsbrugge story Jill Donahue , ( Oct 2, 2020 ) Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's power to do good More Columns Commercial Accelerating commercial success in CAGT Dean Griffiths , ( Mar 22, 2021 ) To build on the successes thus far in cell and gene therapy, pharma must foster further payer, physician and patient buy-in Blended and augmented: Reimagining the role of the rep Andrew Stone , ( Dec 18, 2020 ) The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement Uncorking the compliance bottlenecks in digital Andrew Stone , ( Dec 17, 2020 ) The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology Creating a holistic customer experience Rhonda Siddall , ( Nov 17, 2020 ) Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating a culture to match Adapting to the multichannel imperative: A special report Andrew Stone , ( Oct 8, 2020 ) Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales. More Commercial Access and Evidence Including the caregiver in access submissions Katie Osborne , ( May 23, 2021 ) Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence A burning desire to make a difference for patients Andrew Stone , ( Apr 19, 2020 ) Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients From reactive to predictive: Concerto’s new compositions Andrew Stone , ( Apr 10, 2020 ) Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton Evolving HTA frameworks to accelerate innovation Andrew Stone , ( Mar 14, 2020 ) Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague Can we afford to pay for future cures? Ulrich Neumann , ( Jan 24, 2020 ) Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging More Market Access Patients and Medical Optimizing patient Engagement in Trials Joseph Constance , ( May 23, 2021 ) The importance of involving the patient at all stages of trials post-pandemic has never been clearer Fixing the broken patient search experience Andrew Stone , ( May 23, 2021 ) There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in? The value in measuring the patient experience Andrew Stone , ( Feb 22, 2021 ) Pharma can improve outcomes, products and HCP relationships using technology to capture patients’ day-to-day experience of their disease Better research through patient insights Andrew Stone , ( Jan 26, 2021 ) AstraZeneca’s innovations in chronic kidney disease are pointing the way to new ways of involving patients and RWE to drive new insights and better outcomes Building a health equity culture Andrew Stone , ( Nov 17, 2020 ) Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts More Patients and Medical Latest Videos Michel Pairet, Member of Board of Managing Directors at Boehringer Ingelheim on COVID-19 research Cue Biopharma: Diagnostic & disease detection to transform biopharma Dr Avi Spira: Janssen's use of new technology to intercept lung cancer The Eisenbahnscheinbewegung Risk Act like SARS and go viral with patient centricity Upcoming events View All Events June 2021 FREE WEBINAR: A new era of outsourcing: Improve efficiency and streamline trial solutions with a personalised approach Jun 10, 2021 - Jun 10, 2021 FREE WEBINAR: Develop a Collaborative Delivery Network for Cell and Gene Therapies Jun 15, 2021 - Jun 15, 2021 Digital Health Jun 16, 2021 - Jun 17, 2021 Digital conference, exhibition & networking FREE WEBINAR: Pharma’s climate goals: The roadmap to delivery Jun 17, 2021 - Jun 17, 2021 FREE WEBINAR: Streamline your digital go-to-market strategy for specialty products Jun 24, 2021 - Jun 24, 2021 FREE WEBINAR: The DTC·OS: Empower the patient trial experience Jun 24, 2021 - Jun 24, 2021 September 2021 Pharma Japan Sep 14, 2021 - Sep 16, 2021 Digital Conference, Exhibition & Networking Cell & Gene Therapy Sep 28, 2021 - Sep 29, 2021 Digital Conference, Exhibition & Networking October 2021 Reuters IMPACT Oct 4, 2021 - Oct 7, 2021 Virtual Conference, Networking & Exhibition Pharma Europe (formerly eyeforpharma Barcelona) Oct 12, ...